Lupin Diagnostics eyes 100 labs in five years

Lupin Diagnostics Ltd., a wholly owned subsidiary of Lupin Ltd., has drawn up plans to more than double the number of its laboratories and increase collection centres by threefold across the country in five years, said a top official.

“Right now, we have 36 laboratories and 600 collection centres. Our goal is to have 100 laboratories by FY28 and 2,000 collection centres in five years,” said CEO Ravindra Kumar during a press meet.

On Thursday, Mr. Kumar announced the launch of Regional Reference laboratory in Chennai. Plans are to enter tier II cities such as Coimbatore, Madurai, Tiruchiraplli and Salem and agreements have been signed with the franchisees, he said.

Regarding the expansion of laboratories, he said that each region will have at least 25 units. “Right now, we are present only in East, West and South. We will be entering North by FY27, Kerala and Gujarat soon.”

The number of collection centres will be ramped to 1,000 numbers by FY25 and 2,000 in three years.

While mentioning that 10 out of 36 laboratories have already been accredited by NABL, he said that 10 more are in the pipeline and five would get the accreditation by FY24.

Related Posts

  • Pharma
  • July 26, 2024
  • 126 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 124 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD